Project Number ADDF-50 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2021 View Full Project Details for Towards an integral and sensitive neurophysiological risk biomarkers for asymptomatic detection of Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 8. Novel Analyses, Methodologies and Techniques for Biomarker Discovery and Validation Researcher and Organization Principal Investigator Polania, Rafael Principal Investigator Polania, Rafael Awardee Organization ETH Zurich Contact PI Country Switzerland Project Detail FY Overall Cost $470,007 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
